Consumer / Employer, Health Tech Deloitte: 7 Trends Shaping Healthcare and Life Sciences in 2024 By Marissa Plescia
Consumer / Employer Deloitte: Employers Could Have a Significant Impact on Employees’ Lifespans By Marissa Plescia
BioPharma, Pharma Pharma Returns Slump as Post-Pandemic Realities Set In, Deloitte Report Says By Frank Vinluan
Health Tech, Consumer / Employer Deloitte invests $750M in healthcare, consumer and financial services businesses By Michael Schroeder
Health Tech, Community Deloitte exec: Tech has role in combating racial disparities in health By Joel Berg
Health IT, BioPharma Vineti, Deloitte Consulting partner software systems to improve cell, gene therapy access By Alaric DeArment
Devices & Diagnostics The biotechs that top Deloitte’s Fast 500 Tech: Boston Heart Diagnostics, Novavax and more By Meghana Keshavan
Devices & Diagnostics Which burgeoning medical device & pharma companies landed on Deloitte’s Fast 500 list? By Deanna Pogorelc
Devices & Diagnostics Deloitte report: Device makers and hospitals have a lot of holes to patch in the data network By Veronica Combs
Health IT Keckley predicts Occupy Healthcare and more painful change in “reform 2.0” in his last Deloitte memo By Veronica Combs
